Arañas, Claudio .

HRN: 28-96-12  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/12/2026
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
05/12/2026
05/18/2026
IV
2.5g
Q12
CAP-HR
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  URTI    Compliance to guidelines: Compliant To Guidelines